Is there a potential for therapeutic drug monitoring of subcutaneously administered tocilizumab in patients with rheumatoid arthritis in daily practice?

Show more authors
+ 3
Zohra Layegh
Femke Hooijberg
Carla Bastida
Alwin D R Huitema
Theo Rispens
C Gertjan Wolbink

More about this publication

Clinical and experimental rheumatology

Volume 40
Issue nr. 3
Pages 664-665
Publication date 01-03-2022

Full text links

Publisher website (DOI) 10.55563/clinexprheumatol/xn5i2y
Europe PubMed Central 34796848
Pubmed 34796848

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.